Combining methamphetamine and cannabis was linked to more severe asthma attacks requiring intubation ↗
Co-use of methamphetamine and cannabis linked to higher intubation rates and more severe asthma attacks among hospitalized patients.
Browse more cannabis research, findings, methods, and limitations.
Co-use of methamphetamine and cannabis linked to higher intubation rates and more severe asthma attacks among hospitalized patients.
Swedish nationwide study found moderate antipsychotic doses most effective for preventing psychotic relapse after cannabis-induced psychosis — higher doses added no benefit.
Decade of US crash data shows stronger alcohol and cannabis policies each independently reduce substance-involved motor vehicle deaths.
Medical cannabis improved sleep, fatigue, and pain for spasticity/spasm patients but not physical functioning.
Qualitative study found cancer patients overwhelmed by dispensary product variety, using imprecise dosing and frequently switching between multiple administration routes.
In 923,000+ veterans on opioids, cannabis linked to 11% more suicide attempts; tobacco to more attempts, deaths, and overdose deaths.
Monthly ultra-low-dose THC prevented cognitive decline in Alzheimer mice, with sex-specific anti-inflammatory patterns.
Daily CBD in Alzheimer mice reduced brain immune cell reactivity but did not improve cognition, behavior, or brain volume.
Nature Neuroscience study reveals 2-AG and anandamide have completely separate cellular targets in the hippocampus, with 2-AG signaling to neurons and anandamide signaling to astrocytes.
Analysis of 260,000+ Swedish students over 33 years shows that rising average cannabis use among teens predictably drives increases in heavy use.
Survey of 139 Ghanaian pro footballers found 44.6% used substances, with caffeine dominant and cannabis use under 3%.
Qualitative study finds most new mothers who used cannabis in pregnancy continued postpartum, citing mental health and pain, while wanting better information about breastfeeding risks.
Review maps CBD's extensive receptor interactions beyond the endocannabinoid system, highlighting both therapeutic potential and complexity for Parkinson's disease.
Animal study finds melatonin protects against cannabis-induced reproductive hormone disruption in female rats, with CB1 receptors primarily responsible for the hormonal effects.
Survey of 549 sexual minority men found cannabis users had 83% higher odds of erectile dysfunction, highlighting an understudied intersection of cannabis and sexual health.
ABCD Study found racial discrimination in preteens linked to cannabis use intentions through a pathway of increased perceived accessibility and decreased perceived harm.
Major meta-analysis shows cannabis co-use reduces tobacco quit odds by 35%, but CBD interventions cut cigarette consumption by 40%, suggesting a promising new cessation approach.
RCT with 60 chronic insomnia patients found cannabis oil matched lorazepam for sleep improvement over 4 weeks, with better quality-of-life outcomes and only mild side effects.
Study reveals cisplatin chemotherapy disrupts the endocannabinoid system in hearing cells, and blocking CB2 receptors may protect against the damage.
CBD prevented precancerous colorectal growths in two mouse models by targeting EEF1B2 to suppress immune-blocking cells, enabling stronger anti-tumor immune responses.
Prospective study of 49 dental surgery patients found heavy cannabis users needed significantly more propofol under IV general anesthesia, with a practical risk stratification system.
Case report of a daily cannabis user who developed delusional infestation -- believing parasites were under his skin -- highlighting an unusual presentation of cannabis-associated psychosis.
Review mapped how cannabinoids interfere with drug metabolism through CYP450 enzymes, potentially altering effectiveness of antidepressants, blood thinners, opioids, and more.
Review finds preclinical evidence supporting cannabinoid antitumor activity against skin cancers through multiple mechanisms, with topical CBD formulations as a promising delivery approach.
Analysis of 988 schizophrenia patients found THC-positive individuals had 36% lower odds of metabolic syndrome, with significantly less central obesity.
Systematic review finds 33 clinical trials testing Ozempic-type drugs for addiction, mostly for alcohol and tobacco, with zero trials targeting cannabis use disorder.
Review argues that older adults may be more impaired by cannabis while driving due to age-related changes in metabolism, cognition, and the endocannabinoid system.
Study of IBD patient biopsies found 6 of 10 endocannabinoid system genes dysregulated in inflamed tissue, with CB2 and GPR55 receptors upregulated.
FDA database study of 115 million insured adults found cannabis-related healthcare encounters rose 71% from 2017 to 2022, with no difference by state legalization status.
Review explores how medical cannabis could address the severe symptom burden in head and neck cancer, including pain, nausea, cachexia, and difficulty swallowing.
Longitudinal study of 293 families finds prenatal tobacco-cannabis co-exposure leads to childhood behavioral problems through emotion regulation difficulties, a different pathway than tobacco alone.
Mouse study shows prenatal cannabis exposure combined with adolescent stress increased risk-taking behavior, while neither factor alone had this effect.
First study showing alcohol decreases 2-AG endocannabinoid levels, with the drop linked to less drug liking, suggesting the endocannabinoid system mediates alcohol reward.
Study links gray matter loss in Parkinson's psychosis to CB1 cannabinoid receptor brain distribution, suggesting the endocannabinoid system may play a role in these symptoms.
Systematic review reveals smoking synthetic cannabinoids creates unknown toxic chemicals with brain-damaging potential, with only 9 studies ever investigating these breakdown products.
Qualitative study found veterans in addiction treatment used cannabis to manage chronic pain, anxiety, and sleep — framing it as a harm reduction alternative to more dangerous substances.
Prospective study finds half of colorectal surgery patients can go opioid-free after discharge, but cannabis users were far less likely to achieve this.
Study found longer cannabis use history linked to weaker automatic movement learning and elevated resting brain activity, suggesting altered baseline neural dynamics.
Survey finds 89% of cancer care providers believe cannabis manages symptoms but only 15% feel knowledgeable, revealing a critical education gap in oncology.
Review explored how age-related endocannabinoid system changes and chronic inflammation ('inflammaging') create a rationale for cannabinoid pain therapy in older adults, though clinical evidence is limited.
Review found hemp-derived compounds from seeds, leaves, and flowers show neuroprotective potential across epilepsy, Alzheimer's, Parkinson's, and MS — mostly in preclinical studies.
Retrospective study of 237 breast reconstruction patients found cannabis users reported higher pain and used 52% more opioids, though this was not independent of other factors.
ABCD Study found early adolescents follow distinct trajectories of cannabis expectancy development, with family monitoring and peer substance use as key factors.
National survey of 40,000+ adults reveals bisexual women have 2.57x higher odds of cannabis use, with distinct gender-specific patterns across sexual orientation dimensions.
Study of 4,270 Medicaid infants found no difference in healthcare use or developmental delay at age 3 between cannabis-exposed and unexposed babies.
Web survey of 2,047 Malaysians found 88.4% support medical cannabis based on clinical evidence, with education and low risk perception as strongest predictors.
Study finds lesser-known cannabinoids CBV and THCV reduce pain through both vanilloid and cannabinoid receptor pathways in a genetic model organism.
Survey of 327 college students finds lack of belonging drives cannabis use indirectly through depression and anxiety, suggesting mental health support may be key.
Mouse study shows females develop greater THC tolerance than males after 90 days, with chronic THC increasing anxiety in females and HIV status adding neuroinflammatory complexity.
Study shows 16 cannabis terpenes selectively activate CB1 and CB2 receptors at THC-comparable potency, providing molecular evidence for the entourage effect.